Cognition Therapeutics Stock (NASDAQ: CGTX) stock price, news, charts, stock research, profile.
You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.
Other companies in Cognition Therapeutics’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
Cognition Therapeutics has a consensus price target of $7.67.
The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $0.45 last updated November 21, 2024 at 7:51 PM EST.
There are no upcoming dividends for Cognition Therapeutics.
Cognition Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Cognition Therapeutics.
Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.